LXRX - Lexicon Pharmaceuticals to Host 2024 Investor Day | Benzinga
THE WOODLANDS, Texas, April 18, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced that senior company executives will be joined by leading physicians at the Lexicon 2024 Investor Day on April 22, 2024. The event will be held in New York City from 9:00 a.m. to 12:00 p.m. ET.
Business and scientific updates will be presented by Lonnel Coats, Lexicon's chief executive officer; Jeff Wade, Lexicon's president and chief financial officer; Alan Main, Ph.D., Lexicon's executive vice president, innovation and chemical sciences; Tom Garner, Lexicon's senior vice president and chief commercial officer; and Craig Granowitz, M.D., Ph.D., Lexicon's senior vice president and chief medical officer.
The corporate presentations and panel discussion with renowned medical leaders will highlight Lexicon's strategy and efforts to address major areas of need in:
- Heart Failure
- Diabetic Peripheral Neuropathic Pain
- Hypertrophic Cardiomyopathy
- Type 1 Diabetes
- Obesity and Weight Management
The simultaneous webcast will be available in the "Events" section of the Lexicon website at www.lexpharma.com/events, and a recording ...